Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7138505 Factor VIII:C nucleic acid molecules

Patent 7138505 was granted and assigned to Novartis on November, 2006 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 28 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12071456 Extended recombinant polypeptides and compositions comprising same
0
Edits on 27 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Jun, 2024
Edits on 6 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 6 Sep, 2023
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Carol Pachl0
Daniel Caput0
Frank Masiarz0
George Kuo0
Martha Truett0
Mirella Ezban Rasmussen0
Pablo Valenzuela0
Rae Lyn Burke0
Edits on 31 Aug, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 31 Aug, 2023
Edits made to:
Article (+394 characters)
Article

Patent abstract

Methods and compositions are provided for recombinant DNA production of Factor VIIIC and truncated derivatives thereof. Based on amino acid sequences, probes are developed for isolating messenger RNA, cDNA and/or chromosomal DNA encoding for Factor VIIIC. The Factor VIIIC gene in its entirety, a fragment thereof, or a cDNA is then used for expression of Factor VIIIC in a host.

Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 Jul, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=071385050
Edits on 28 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11685771 Recombinant factor VIII proteins
0
Edits on 18 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 18 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07138505 Factor VIII:C nucleic acid molecules US Patent 7138505 Factor VIII:C nucleic acid molecules

Infobox
Patent Number
071385050
Patent Number
71385050
Edits on 24 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Novartis
Novartis
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
071385050
Date of Patent
November 21, 2006
0
Patent Application Number
075693760
Date Filed
August 13, 1990
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=071385050
Patent Primary Examiner
‌
Joseph Woitach
0
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07138505
Edits on 19 Nov, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 19 Nov, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07138505 Factor VIII:C nucleic acid molecules

Infobox
Is a
Patent
Patent
Current assignee
Novartis
Novartis
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07138505
Date of patent
November 21, 2006
Patent application number
07569376
Date Filed
August 13, 1990
Patent primary examiner
‌
Joseph Woitach

Find more entities like US Patent 7138505 Factor VIII:C nucleic acid molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo